GenScript Biotech Corporation is the world’s leading technology and service provider of life science R&D and manufacture. Built upon its solid gene synthesis technology, GenScript Biotech is divided into four major platforms including the life science service and product platform, the biologics contract development and manufacturing organization (CDMO) platform, the industrial synthetic products platform, and the integrated global cell therapy platform.
GenScript Biotech provides life sciences services and products to scientists in over 200 countries worldwide, including gene synthesis, DNA and RNA oligo synthesis with specialties in CRISPR sgRNA/NGS/qPRC/tRNA/siRNA oligos, IVT mRNA/circRNA synthesis and LNP formulation, as well as peptide synthesis, protein and antibody production services. GenScript also provides RUO to cGMP grade oligo and peptide services globally.
Driven by the corporate mission of “make people and nature healthier through biotechnology”, GenScript Biotech strives to become the most trustworthy biotech company in the world.